White House releases “Bioeconomy Blueprint”
May 1st, 2012 | 
Author: The Obama administration's strategy to spur growth in the U.S. biomedical industry includes prioritizing high-risk/high-reward research, offering prizes for innovation, encouraging collaboration between corporations and universities to move products from the lab to the market, and streamlining the regulatory process. Some of the programs cited in the report are under way, and the White House does not commit to any "grand challenges."
Posted in Uncategorized